Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Keith Flaherty »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Keith F. Lewin < Keith Flaherty < Keith Foster  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000503 (2017) Reinhard Dummer [Suisse] ; Dirk Schadendorf [Allemagne] ; Paolo A. Ascierto [Italie] ; Ana Arance [Espagne] ; Caroline Dutriaux [France] ; Anna Maria Di Giacomo [Italie] ; Piotr Rutkowski [Pologne] ; Michele Del Vecchio [Italie] ; Ralf Gutzmer [Allemagne] ; Mario Mandala [Italie] ; Luc Thomas [France] ; Lev Demidov [Russie] ; Claus Garbe [Allemagne] ; David Hogg [Canada] ; Gabriella Liszkay [Hongrie] ; Paola Queirolo [Italie] ; Ernesto Wasserman [États-Unis] ; James Ford [États-Unis] ; Marine Weill [Suisse] ; L Andres Sirulnik [États-Unis] ; Valentine Jehl [Suisse] ; Viviana Boz N [États-Unis] ; Georgina V. Long [Australie] ; Keith Flaherty [États-Unis]Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
000D46 (2015) Jean Jacques Grob [France] ; Georgina V. Long [Australie] ; Dirk Schadendorf [Allemagne] ; Keith Flaherty [États-Unis]Disease kinetics for decision-making in advanced melanoma: a call for scenario-driven strategy trials.
000D65 (2015) Georgina V. Long [Australie] ; Daniil Stroyakovskiy [Russie] ; Helen Gogas [Grèce] ; Evgeny Levchenko [Russie] ; Filippo De Braud [Italie] ; James Larkin [Royaume-Uni] ; Claus Garbe [Allemagne] ; Thomas Jouary [France] ; Axel Hauschild [Allemagne] ; Jean-Jacques Grob [France] ; Vanna Chiarion-Sileni [Italie] ; Celeste Lebbe [France] ; Mario Mandalà [Italie] ; Michael Millward [Australie] ; Ana Arance [Espagne] ; Igor Bondarenko [Ukraine] ; John B A G. Haanen [Pays-Bas] ; Johan Hansson [Suède] ; Jochen Utikal [Allemagne] ; Virginia Ferraresi [Italie] ; Nadezhda Kovalenko [Russie] ; Peter Mohr [Allemagne] ; Volodymr Probachai [Ukraine] ; Dirk Schadendorf [Allemagne] ; Paul Nathan [Royaume-Uni] ; Caroline Robert [France] ; Antoni Ribas [États-Unis] ; Douglas J. Demarini [États-Unis] ; Jhangir G. Irani [États-Unis] ; Suzanne Swann [États-Unis] ; Jeffrey J. Legos [États-Unis] ; Fan Jin [États-Unis] ; Bijoyesh Mookerjee [États-Unis] ; Keith Flaherty [États-Unis]Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
000D76 (2015) Jean Jacques Grob [France] ; Mayur M. Amonkar [États-Unis] ; Boguslawa Karaszewska [Pologne] ; Jacob Schachter [Israël] ; Reinhard Dummer [Suisse] ; Andrzej Mackiewicz [Pologne] ; Daniil Stroyakovskiy [Russie] ; Kamil Drucis [Pologne] ; Florent Grange [France] ; Vanna Chiarion-Sileni [Italie] ; Piotr Rutkowski [Pologne] ; Mikhail Lichinitser [Russie] ; Evgeny Levchenko [Russie] ; Pascal Wolter [Belgique] ; Axel Hauschild [Allemagne] ; Georgina V. Long [Australie] ; Paul Nathan [Royaume-Uni] ; Antoni Ribas [États-Unis] ; Keith Flaherty [États-Unis] ; Peng Sun [États-Unis] ; Jeffrey J. Legos [États-Unis] ; Diane Opatt Mcdowell [États-Unis] ; Bijoyesh Mookerjee [États-Unis] ; Dirk Schadendorf [Allemagne] ; Caroline Robert [France]Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
4Melanoma (drug therapy)
3Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
2Adult
2Aged
2Aged, 80 and over
2Antineoplastic Combined Chemotherapy Protocols (adverse effects)
2Disease Progression
2Disease-Free Survival
2Female
2Imidazoles (administration & dosage)
2Male
2Melanoma (genetics)
2Melanoma (mortality)
2Melanoma (secondary)
2Middle Aged
2Oximes (administration & dosage)
2Prognosis
2Proto-Oncogene Proteins B-raf (genetics)
2Pyridones (administration & dosage)
2Pyrimidinones (administration & dosage)
2Risk Factors
2Skin Neoplasms (drug therapy)
2Skin Neoplasms (mortality)
2Skin Neoplasms (pathology)
2Treatment Outcome
1Administration, Oral
1Algorithms
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Benzimidazoles (administration & dosage)
1Biomarkers, Tumor (genetics)
1Clinical Trials as Topic (methods)
1Critical Pathways
1DNA Mutational Analysis
1Dacarbazine (administration & dosage)
1Decision Support Techniques
1Double-Blind Method
1Drug Administration Schedule
1Drug Therapy, Combination
1Follow-Up Studies
1GTP Phosphohydrolases (genetics)
1Genetic Predisposition to Disease
1Imidazoles (adverse effects)
1Imidazoles (therapeutic use)
1Indoles (administration & dosage)
1Indoles (adverse effects)
1Indoles (therapeutic use)
1Intention to Treat Analysis
1Kinetics
1MAP Kinase Kinase Kinases (antagonists & inhibitors)
1MAP Kinase Kinase Kinases (metabolism)
1Melanoma (pathology)
1Membrane Proteins (genetics)
1Mutation
1Mutation (genetics)
1Neoplasm Staging
1Oximes (adverse effects)
1Oximes (therapeutic use)
1Phenotype
1Predictive Value of Tests
1Prospective Studies
1Protein Kinase Inhibitors (administration & dosage)
1Protein Kinase Inhibitors (adverse effects)
1Protein Kinase Inhibitors (therapeutic use)
1Proto-Oncogene Proteins B-raf (antagonists & inhibitors)
1Pyridones (adverse effects)
1Pyridones (therapeutic use)
1Pyrimidinones (adverse effects)
1Pyrimidinones (therapeutic use)
1Quality of Life
1Research Design
1Risk Assessment
1Skin Neoplasms (genetics)
1Sulfonamides (administration & dosage)
1Sulfonamides (adverse effects)
1Sulfonamides (therapeutic use)
1Surveys and Questionnaires
1Survival Rate
1Time Factors
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Keith Flaherty" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Keith Flaherty" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Keith Flaherty
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024